Frontlight ResearchEarly access
CompletedNo phase
Longitudinal Monitoring of Inflammation in Cirrhosis
Key facts
- Who runs it
- Hunter Holmes Mcguire Veteran Affairs Medical Center
- Where
- Richmond, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 85 people enrolled
- Started
- 1 Sept 2022
- Ended
- 31 Jul 2024
- Type of study
- Interventional, 3 groups
- Treatments tested
- Sensor skin
- Record updated
- 2 August 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (20)Hide the full registry criteria
Who can take part
- Age >18 years
- Able to give consent
- Age >18 years
- Able to give consent
- Cirrhosis defined by any one of the following; Cirrhosis on liver biopsy or transient wave elastography; Nodular liver on imaging; Endoscopic or radiological evidence of varices in a patient with chronic liver disease; Platelet count <150,000/mm3 and AST/ALT ratio >1 in a patient with chronic liver disease; Patients with frank decompensation (ascites, HE, variceal bleeding, hepato-pulmonary syndrome)
- Age >18 years
- Able to give consent
- Cirrhosis defined by any one of the following; Cirrhosis on liver biopsy or transient wave elastography; Nodular liver on imaging; Endoscopic or radiological evidence of varices in a patient with chronic liver disease; Platelet count <150,000/mm3 and AST/ALT ratio >1 in a patient with chronic liver disease; Patients with frank decompensation (ascites, HE, variceal bleeding, hepato-pulmonary syndrome)
Who cannot take part
- Chronic diseases
- Inflammatory bowel disease or other diseases that require immunosuppressive therapy use; Inpatients with Cirrhosis:
- Inflammatory bowel disease or other diseases that require immunosuppressive therapy use
- Unable/unwilling to consent
- Unable to come in daily or be available daily for 3 days; Outpatients with Cirrhosis:
- Unable/unwilling to consent
- Unclear diagnosis of cirrhosis
- Unable to come in daily or be available daily for 3 days
- Unable/unwilling to consent
- Unclear diagnosis of cirrhosis
- Unable to be seen daily or able to come in daily for 3 days (if discharged in between)
Other criteria
- Healthy Volunteers
Where in United States
- Hunter Holmes McGuire VA Medical CenterRichmond, United States
About the trial
What the trial wants to find out
Longitudinal monitoring of inflammation using skin devices may help predict outcomes compared to traditional blood draws
The 3 groups in the trial
- Healthy controlsTreatment being tested
Healthy controls will receive the sensors
Treatment: Sensor skin
- Outpatients with cirrhosisTreatment being tested
Outpatients with cirrhosis will receive the sensors
Treatment: Sensor skin
- Inpatients with cirrhosisTreatment being tested
Inpatients with cirrhosis will receive the sensors
Treatment: Sensor skin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 2 August 2024